MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Garg, Neha ^a,b   Vijayakumar, Thusyanth ^a,b   Bakhshinyan, David ^a,b   Venugopal, Chitra ^a,b   Singh, Sheila K ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 10; MICRORNA 107; MICRORNA 124; MICRORNA 125B; MICRORNA 1275; MICRORNA 128; MICRORNA 129; MICRORNA 137; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 152; MICRORNA 153; MICRORNA 181A; MICRORNA 181B; MICRORNA 181C; MICRORNA 221; MICRORNA 222; MICRORNA 25; MICRORNA 300; MICRORNA 324 5P; MICRORNA 326; MICRORNA 34A; MICRORNA 451; MICRORNA 622; MICRORNA 7; MICRORNA 9; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATYPICAL TERATOID RHABDOID TUMOR; BRAIN CELL; BRAIN SURGERY; BRAIN TUMOR INITIATING CELL; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CRANIOPHARYNGIOMA; DRUG RESISTANCE; EPENDYMOMA; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOPHYSIS ADENOMA; MEDULLOBLASTOMA; NONHUMAN; ONCOGENE; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; RNA INTERFERENCE; TUMOR CELL; TUMOR SUPPRESSOR GENE;

EID: 84929631217     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/141793     Document Type: Review

References (195)

1. D. P. Bartel and C.-Z. Chen, "Micromanagers of gene expression: the potentially widespread influence of metazoan microR-NAs," Nature Reviews Genetics, vol. 5, no. 5, pp. 396-400, 2004.
2. H. R. Chiang, L. W. Schoenfeld, J. G. Ruby et al., "Mammalian microRNAs: experimental evaluation of novel and previously annotated genes," Genes & Development, vol. 24, no. 10, pp. 992-1009, 2010.
3. S. Vasudevan, Y. Tong, and J. A. Steitz, "Switching from repression to activation: microRNAs can up-regulate translation," Science, vol. 318, no. 5858, pp. 1931-1934, 2007.
4. S. Lee and S. Vasudevan, "Post-transcriptional stimulation of gene expression by MicroRNAs," Advances in Experimental Medicine and Biology, vol. 768, pp. 97-126, 2013.
5. E. Lund, S. Güttinger, A. Calado, J. E. Dahlberg, and U. Kutay, "Nuclear export of microRNA precursors," Science, vol. 303, no. 5654, pp. 95-98, 2004.
6. P. M. van Wynsberghe, S.-P. Chan, F. J. Slack, and A. E. Pasquinelli, "Analysis of microRNA expression and function," Methods in Cell Biology, vol. 106, pp. 219-252, 2011.
7. S. Diederichs and D. A. Haber, "Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression," Cell, vol. 131, no. 6, pp. 1097-1108, 2007.
8. B. P. Lewis, C. B. Burge, and D. P. Bartel, "Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets," Cell, vol. 120, no. 1, pp. 15-20, 2005.
9. A. Gaur, D. A. Jewell, Y. Liang et al., "Characterization of microRNA expression levels and their biological correlates in human cancer cell lines," Cancer Research, vol. 67, no. 6, pp. 2456-2468, 2007.
10. B. M. Ryan, A. I. Robles, and C. C. Harris, "Genetic variation in microRNA networks: the implications for cancer research," Nature Reviews Cancer, vol. 10, no. 6, pp. 389-402, 2010.
11. G. A. Calin, C. Sevignani, C. D. Dumitru et al., "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999-3004, 2004.
12. J. Piriyapongsa, I. K. Jordan, A. B. Conley, T. Ronan, and N. R. Smalheiser, "Transcription factor binding sites are highly enriched within microRNA precursor sequences," Biology Direct, vol. 6, article 61, 2011.
13. B. N. Davis, A. C. Hilyard, P. H. Nguyen, G. Lagna, and A. Hata, "Smad proteins bind a conserved RNA sequence to promote MicroRNA maturation by Drosha," Molecular Cell, vol. 39, no. 3, pp. 373-384, 2010.
14. L. He, X. He, L. P. Lim et al., "A microRNA component of the p53 tumour suppressor network," Nature, vol. 447, no. 7148, pp. 1130-1134, 2007.
15. Y. Sylvestre, V. de Guire, E. Querido et al., "An E2F/miR-20a autoregulatory feedback loop," Journal of Biological Chemistry, vol. 282, no. 4, pp. 2135-2143, 2007.
16. M. Dews, A. Homayouni, D. Yu et al., "Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster," Nature Genetics, vol. 38, no. 9, pp. 1060-1065, 2006.
17. A. Lujambio, S. Ropero, E. Ballestar et al., "Genetic unmasking of an epigenetically silenced microRNA in human cancer cells," Cancer Research, vol. 67, no. 4, pp. 1424-1429, 2007.
18. J. M. Thomson, M. Newman, J. S. Parker, E. M. Morin-Kensicki, T. Wright, and S. M. Hammond, "Extensive post-transcriptional regulation of microRNAs and its implications for cancer," Genes and Development, vol. 20, no. 16, pp. 2202-2207, 2006.
19. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation," Cell, vol. 144, no. 5, pp. 646-674, 2011.
20. C. E. Weber and P. C. Kuo, "The tumor microenvironment," Surgical Oncology, vol. 21, no. 3, pp. 172-177, 2012.
21. J. Dou and N. Gu, "Emerging strategies for the identification and targeting of cancer stem cells," Tumor Biology, vol. 31, no. 4, pp. 243-253, 2010.
22. M. S. Wicha, S. Liu, and G. Dontu, "Cancer stem cells: an old idea - a paradigm shift," Cancer Research, vol. 66, no. 4, pp. 1883-1890, 2006.
23. D. Bonnet and J. E. Dick, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell," Nature Medicine, vol. 3, no. 7, pp. 730-737, 1997.
24. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, "Prospective identification of tumorigenic breast cancer cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983-3988, 2003.
25. S. K. Singh, C. Hawkins, I. D. Clarke et al., "Identification of human brain tumour initiating cells," Nature, vol. 432, no. 7015, pp. 396-401, 2004.
26. S. Bao, Q. Wu, R. E. McLendon et al., "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response," Nature, vol. 444, no. 7120, pp. 756-760, 2006.
27. S. K. Singh, I. D. Clarke, T. Hide, and P. B. Dirks, "Cancer stem cells in nervous system tumors," Oncogene, vol. 23, no. 43, pp. 7267-7273, 2004.
28. R. Galli, E. Binda, U. Orfanelli et al., "Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma," Cancer Research, vol. 64, no. 19, pp. 7011-7021, 2004.
29. H. D. Hemmati, I. Nakano, J. A. Lazareff et al., "Cancerous stem cells can arise from pediatric brain tumors," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15178-15183, 2003.
30. A. Capela and S. Temple, "LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal," Neuron, vol. 35, no. 5, pp. 865-875, 2002.
31. T.-A. Read, M. P. Fogarty, S. L. Markant et al., "Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma," Cancer Cell, vol. 15, no. 2, pp. 135-147, 2009.
32. M. J. Son, K. Woolard, D.-H. Nam, J. Lee, and H. A. Fine, "SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma," Cell Stem Cell, vol. 4, no. 5, pp. 440-452, 2009.
33. U. Karsten and S. Goletz, "What makes cancer stem cell markers different?" Springer Plus, vol. 2, no. 1, pp. 1-8, 2013.
34. M. Abdouh, S. Facchino, W. Chatoo, V. Balasingam, J. Ferreira, and G. Bernier, "BMI1 sustains human glioblastoma multiforme stem cell renewal," The Journal of Neuroscience, vol. 29, no. 28, pp. 8884-8896, 2009.
35. F. Verginelli, A. Perin, R. Dali et al., "Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth," Nature Communications, vol. 4, article 2956, 2013.
36. D. Bexell, S. Gunnarsson, P. Siesjö, J. Bengzon, and A. Darabi, "CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas," International Journal of Cancer, vol. 125, no. 1, pp. 15-22, 2009.
37. K. K. Velpula, V. R. Dasari, A. J. Tsung, D. H. Dinh, and J. S. Rao, "Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1," Oncotarget, vol. 2, no. 12, pp. 1028-1042, 2011.
38. C. O. Rodini, D. E. Suzuki, N. Saba-Silva et al., "Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma," Journal of Neuro-Oncology, vol. 106, no. 1, pp. 71-79, 2012.
39. K. Mitsui, Y. Tokuzawa, H. Itoh et al., "The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells," Cell, vol. 113, no. 5, pp. 631-642, 2003.
40. N. Garg, A. Po, E. Miele et al., "MicroRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1," The EMBO Journal, vol. 32, no. 21, pp. 2819-2832, 2013.
41. A. Po, E. Ferretti, E. Miele et al., "Hedgehog controls neural stem cells through p53-independent regulation of Nanog," The EMBO Journal, vol. 29, no. 15, pp. 2646-2658, 2010.
42. M. Zbinden, A. Duquet, A. Lorente-Trigos, S.-N. Ngwabyt, I. Borges, and A. Ruiz I. Altaba, "NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53," EMBO Journal, vol. 29, no. 15, pp. 2659-2674, 2010.
43. J. Douville, R. Beaulieu, and D. Balicki, "ALDH1 as a functional marker of cancer stem and progenitor cells," Stem Cells and Development, vol. 18, no. 1, pp. 17-26, 2009.
44. A. E. Stacy, P. J. Jansson, and D. R. Richardson, "Molecular pharmacology of ABCG2 and its role in chemoresistance," Molecular Pharmacology, vol. 84, no. 5, pp. 655-669, 2013.
45. M. A. Varela, T. C. Roberts, and M. J. A. Wood, "Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy," Neurotherapeutics, vol. 10, no. 4, pp. 621-631, 2013.
46. C. L. Gladson, R. A. Prayson, and W. M. Liu, "The pathobiology of glioma tumors," Annual Review of Pathology: Mechanisms of Disease, vol. 5, pp. 33-50, 2010.
47. B. A. Kohler, E. Ward, B. J. McCarthy et al., "Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system," Journal of the National Cancer Institute, vol. 103, no. 9, pp. 714-736, 2011.
48. R. Stupp, M. E. Hegi, W. P. Mason et al., "Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial," The Lancet Oncology, vol. 10, no. 5, pp. 459-466, 2009.
49. T. N. Ignatova, V. G. Kukekov, E. D. Laywell, O. N. Suslov, F. D. Vrionis, and D. A. Steindler, "Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro," Glia, vol. 39, no. 3, pp. 193-206, 2002.
50. G. Tabatabai and M. Weller, "Glioblastoma stem cells," Cell and Tissue Research, vol. 343, no. 3, pp. 459-465, 2011.
51. C. Liu, J. C. Sage, M. R. Miller et al., "Mosaic analysis with double markers reveals tumor cell of origin in glioma," Cell, vol. 146, no. 2, pp. 209-221, 2011.
52. C. Chua, N. Zaiden, K.-H. Chong et al., "Characterization of a side population of astrocytoma cells in response to temozolomide: laboratory investigation," Journal of Neurosurgery, vol. 109, no. 5, pp. 856-866, 2008.
53. Z. Huang, L. Cheng, O. A. Guryanova, Q. Wu, and S. Bao, "Cancer stem cells in glioblastoma - molecular signaling and therapeutic targeting," Protein and Cell, vol. 1, no. 7, pp. 638-655, 2010.
54. S. A. Ciafrè, S. Galardi, A. Mangiola et al., "Extensive modulation of a set of microRNAs in primary glioblastoma," Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1351-1358, 2005.
55. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, "MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells," Cancer Research, vol. 65, no. 14, pp. 6029-6033, 2005.
56. L. Shi, J. Zhang, T. Pan et al., "MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation," Brain Research, vol. 1312, pp. 120-126, 2010.
57. B. Zhao, E.-B. Bian, J. Li, and J. Li, "New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs," Journal of Cellular Physiology, vol. 229, no. 9, pp. 1141-1147, 2014.
58. N. Wu, L. Xiao, X. Zhao et al., "miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2," FEBS Letters, vol. 586, no. 21, pp. 3831-3839, 2012.
59. J. Godlewski, M. O. Nowicki, A. Bronisz et al., "Targeting of the Bmi-1 oncogene/stem cell renewal factor by MicroRNA-128 inhibits glioma proliferation and self-renewal," Cancer Research, vol. 68, no. 22, pp. 9125-9130, 2008.
60. T. Papagiannakopoulos, D. Friedmann-Morvinski, P. Neveu et al., "Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases," Oncogene, vol. 31, no. 15, pp. 1884-1895, 2012.
61. Z.-M. Shi, J. Wang, Z. Yan et al., "MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1," PLoS ONE, vol. 7, no. 3, Article ID e32709, 2012.
62. Y. Zhang, T. Chao, R. Li et al., "MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a," Journal of Molecular Medicine, vol. 87, no. 1, pp. 43-51, 2009.
63. S. Zhao, H. Liu, Y. Liu et al., "MiR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells," Cancer Letters, vol. 333, no. 2, pp. 253-260, 2013.
64. S. Zhao, Y. Deng, Y. Liu et al., "MicroRNA-153 is tumor suppressive in glioblastoma stem cells," Molecular Biology Reports, vol. 40, no. 4, pp. 2789-2798, 2013.
65. B. Kefas, J. Godlewski, L. Comeau et al., "microRNA-7 inhibits the epidermal growth factor receptor and the akt pathway and is down-regulated in glioblastoma," Cancer Research, vol. 68, no. 10, pp. 3566-3572, 2008.
66. L. Shi, Z. Wang, G. Sun, Y. Wan, J. Guo, and X. Fu, "MiR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2," NeuroMolecular Medicine, vol. 16, no. 2, pp. 517-528, 2014.
67. Y. Li, F. Guessous, Z. Ying et al., "MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes," Cancer Research, vol. 69, no. 19, pp. 7569-7576, 2009.
68. F. Guessous, Y. Zhang, A. Kofman et al., "microRNA-34a is tumor suppressive in brain tumors and glioma stem cells," Cell Cycle, vol. 9, no. 6, pp. 1031-1036, 2010.
69. S. S. Rathod, S. B. Rani, M. Khan, D. Muzumdar, and A. Shiras, "Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways," FEBS Open Bio, vol. 4, pp. 485-495, 2014.
70. Z. Wu, Y. Wu, Y. Tian et al., "Differential effects of miR-34c-3p and miR-34c-5p on the proliferation, apoptosis and invasion of glioma cells," Oncology Letters, vol. 6, no. 5, pp. 1447-1452, 2013.
71. J. Mei, R. Bachoo, and C.-L. Zhang, "MicroRNA-146a inhibits glioma development by targeting Notch1," Molecular and Cellular Biology, vol. 31, no. 17, pp. 3584-3592, 2011.
72. L. Chen, X.-R. Chen, F.-F. Chen et al., "MicroRNA-107 inhibits U87 glioma stem cells growth and invasion," Cellular and Molecular Neurobiology, vol. 33, no. 5, pp. 651-657, 2013.
73. B. Kefas, L. Comeau, D. H. Floyd et al., "The neuronal microRNA miR-326 acts in a feedback loop with Notch and has therapeutic potential against brain tumors," Journal of Neuroscience, vol. 29, no. 48, pp. 15161-15168, 2009.
74. R. Zhang, H. Luo, S. Wang et al., "miR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells," Journal of Neuro-Oncology, vol. 121, no. 1, pp. 63-72, 2015.
75. J. Ma, Y. Yao, P. Wang et al., "MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kruppel-like factor 4," Cancer Letters, vol. 355, no. 1, pp. 85-95, 2014.
76. Y. Tu, X. Gao, G. Li et al., "MicroRNA-218 inhibits glioma invasion, migration, proliferation, and Cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1," Cancer Research, vol. 73, no. 19, pp. 6046-6055, 2013.
77. J. Silber, D. A. Lim, C. Petritsch et al., "miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells," BMC Medicine, vol. 6, article 14, 2008.
78. H. Xia, W. K. C. Cheung, S. S. Ng et al., "Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells," The Journal of Biological Chemistry, vol. 287, no. 13, pp. 9962-9971, 2012.
79. A. Bier, N. Giladi, N. Kronfeld et al., "MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1," Oncotarget, vol. 4, no. 5, pp. 665-676, 2013.
80. S. Tamim, D. T. Vo, P. J. Uren et al., "Genomic analyses reveal broad impact of miR-137 on genes associated with malignant transformation and neuronal differentiation in glioblastoma cells," PLoS ONE, vol. 9, no. 1, Article ID e85591, 2014.
81. Y. Tian, Y. Nan, L. Han et al., "MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma," International Journal of Oncology, vol. 40, no. 4, pp. 1105-1112, 2012.
82. H. Gal, G. Pandi, A. A. Kanner et al., "MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells," Biochemical and Biophysical Research Communications, vol. 376, no. 1, pp. 86-90, 2008.
83. B. Peng, S. Hu, Q. Jun et al., "MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma," Molecular and Cellular Biochemistry, vol. 379, no. 1-2, pp. 51-58, 2013.
84. D. Men, Y. Liang, and L. Chen, "Decreased expression of microRNA-200b is an independent unfavorable prognostic factor for glioma patients," Cancer Epidemiology, vol. 38, no. 2, pp. 152-156, 2014.
85. Q. Liu, H. Tang, X. Liu et al., "MiR-200b as a prognostic factor targets multiple members of RAB family in glioma," Medical Oncology, vol. 31, no. 3, article 859, 2014.
86. Y. Su, Q. He, L. Deng et al., "MiR-200a impairs glioma cell growth, migration, and invasion by targeting SIM2-s," NeuroReport, vol. 25, no. 1, pp. 12-17, 2014.
87. M.-F. Lang, S. Yang, C. Zhao et al., "Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells," PLoS ONE, vol. 7, no. 4, Article ID e36248, 2012.
88. F. Guessous, M. Alvarado-Velez, L. Marcinkiewicz et al., "Oncogenic effects of miR-10b in glioblastoma stem cells," Journal of Neuro-Oncology, vol. 112, no. 2, pp. 153-163, 2013.
89. L. He, J. M. Thomson, M. T. Hemann et al., "A microRNA polycistron as a potential human oncogene," Nature, vol. 435, no. 7043, pp. 828-833, 2005.
90. D. Schraivogel, L. Weinmann, D. Beier et al., "CAMTA1 is a novel tumour suppressor regulated by miR-9/9&z.ast; in glioblastoma stem cells," The EMBO Journal, vol. 30, no. 20, pp. 4309-4322, 2011.
91. A. Ernst, B. Campos, J. Meier et al., "De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures," Oncogene, vol. 29, no. 23, pp. 3411-3422, 2010.
92. E. Miele, F. R. Buttarelli, A. Arcella et al., "High-throughput microRNA profiling of pediatric high-grade gliomas," NeuroOncology, vol. 16, no. 2, pp. 228-240, 2014.
93. X. H. D. Chan, S. Nama, F. Gopal et al., "Targeting glioma stem cells by functional inhibition of a prosurvival oncomiR-138 in malignant gliomas," Cell Reports, vol. 2, no. 3, pp. 591-602, 2012.
94. D. H. Floyd, Y. Zhang, B. K. Dey et al., "Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim," PLoS ONE, vol. 9, no. 5, Article ID e96239, 2014.
95. Y. Yao, Y. Xue, J. Ma et al., "MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways," PLoS ONE, vol. 9, no. 4, Article ID e95060, 2014.
96. K. Katsushima, K. Shinjo, A. Natsume et al., "Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells," The Journal of Biological Chemistry, vol. 287, no. 33, pp. 27396-27406, 2012.
97. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., "The 2007 WHO classification of tumours of the central nervous system," Acta Neuropathologica, vol. 114, no. 2, pp. 97-109, 2007.
98. B. S. Paugh, C. Qu, C. Jones et al., "Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease," Journal of Clinical Oncology, vol. 28, no. 18, pp. 3061-3068, 2010.
99. D. K. Birks, V. N. Barton, A. M. Donson, M. H. Handler, R. Vibhakar, and N. K. Foreman, "Survey of MicroRNA expression in pediatric brain tumors," Pediatric Blood and Cancer, vol. 56, no. 2, pp. 211-216, 2011.
100. G. Gatta, G. Zigon, R. Capocaccia et al., "Survival of European children and young adults with cancer diagnosed 1995-2002," European Journal of Cancer, vol. 45, no. 6, pp. 992-1005, 2009.
101. D. W. Parsons, M. Li, X. Zhang et al., "The genetic landscape of the childhood cancer medulloblastoma," Science, vol. 331, no. 6016, pp. 435-439, 2011.
102. Y.-J. Cho, A. Tsherniak, P. Tamayo et al., "Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome," Journal of Clinical Oncology, vol. 29, no. 11, pp. 1424-1430, 2011.
103. D. W. Ellison, J. Dalton, M. Kocak et al., "Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups," Acta Neuropathologica, vol. 121, no. 3, pp. 381-396, 2011.
104. P. A. Northcott, D. J. H. Shih, M. Remke et al., "Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples," Acta Neuropathologica, vol. 123, no. 4, pp. 615-626, 2012.
105. S. L. Palmer, W. E. Reddick, and A. Gajjar, "Understanding the cognitive impact on children who are treated for medulloblastoma," Journal of Pediatric Psychology, vol. 32, no. 9, pp. 1040-1049, 2007.
106. V. Ramaswamy, M. Remke, E. Bouffet et al., "Recurrence patternsacross medulloblastoma subgroups: an integrated clinical and molecular analysis," The Lancet Oncology, vol. 14, no. 12, pp. 1200-1207, 2013.
107. D. O. Vidal, M. M. C. Marques, L. F. Lopes, and R. M. Reis, "The role of microRNAs in medulloblastoma," Pediatric Hematology and Oncology, vol. 30, no. 5, pp. 367-378, 2013.
108. E. Ferretti, E. De Smaele, E. Miele et al., "Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells," The EMBO Journal, vol. 27, no. 19, pp. 2616-2627, 2008.
109. E. Ferretti, E. de Smaele, A. Po et al., "MicroRNA profiling in human medulloblastoma," International Journal of Cancer, vol. 124, no. 3, pp. 568-577, 2009.
110. J. Pierson, B. Hostager, R. Fan, and R. Vibhakar, "Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma," Journal of Neuro-Oncology, vol. 90, no. 1, pp. 1-7, 2008.
111. K. K. W. Li, J. C. S. Pang, A. K. K. Ching et al., "miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1," Human Pathology, vol. 40, no. 9, pp. 1234-1243, 2009.
112. S. Venkataraman, D. K. Birks, I. Balakrishnan et al., "MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma," Journal of Biological Chemistry, vol. 288, no. 3, pp. 1918-1928, 2013.
113. L. Garzia, I. Andolfo, E. Cusanelli et al., "MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma," PLoS ONE, vol. 4, no. 3, Article ID e4998, 2009.
114. I. Andolfo, L. Liguori, P. De Antonellis et al., "The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma," Neuro-Oncology, vol. 14, no. 5, pp. 596-612, 2012.
115. P. de Antonellis, C. Medaglia, E. Cusanelli et al., "MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+tumor-propagating cells and supports neural differentiation in medulloblastoma," PLoS ONE, vol. 6, no. 9, 2011.
116. S. D. Weeraratne, V. Amani, A. Neiss et al., "miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma," Neuro-Oncology, vol. 13, no. 2, pp. 165-175, 2011.
117. T. Thor, A. Künkele, K. W. Pajtler et al., "MiR-34a deficiency accelerates medulloblastoma formation in vivo," International Journal of Cancer, vol. 136, no. 10, pp. 2293-2303, 2015.
118. A. Gokhale, R. Kunder, A. Goel et al., "Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway," Journal of Cancer Research and Therapeutics, vol. 6, no. 4, pp. 521-529, 2010.
119. S. K. Singh, I. D. Clarke, M. Terasaki et al., "Identification of a cancer stem cell in human brain tumors," Cancer Research, vol. 63, no. 18, pp. 5821-5828, 2003.
120. F. Wang, M. Remke, K. Bhat et al., "A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma,"Oncotarget, vol. 6, no. 5, pp. 2709-2724, 2015.
121. K. Hemmesi, M. L. Squadrito, P. Mestdagh et al., "miR-135a inhibits cancer stem cell-driven medulloblastoma development by directly repressing Arhgef6 expression," Stem Cells, vol. 33, no. 5, pp. 1377-1389, 2015.
122. T. Uziel, F. V. Karginov, S. Xie et al., "The miR-17-92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 8, pp. 2812-2817, 2009.
123. P. A. Northcott, A. Fernandez-L, J. P. Hagan et al., "The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors," Cancer Research, vol. 69, no. 8, pp. 3249-3255, 2009.
124. A. H. C. Bai, T. Milde, M. Remke et al., "MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma,"Acta Neuropathologica, vol. 123, no. 4, pp. 529-538, 2012.
125. Y.-Y. Lee, Y.-P. Yang, M.-C. Huang et al., "MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors," Cell Transplantation, vol. 23, no. 4-5, pp. 669-690, 2014.
126. Z. Zhang, S. Li, and S. Y. Cheng, "The miR-183 approximately 96 approximately 182 cluster promotes tumorigenesis in a mouse model of medulloblastoma," Journal of Biomedical Research, vol. 27, no. 6, pp. 486-494, 2013.
127. E. Grunder, R. D'Ambrosio, G. Fiaschetti et al., "microRNA-21 suppression impedes medulloblastoma cell migration," European Journal of Cancer, vol. 47, no. 16, pp. 2479-2490, 2011.
128. Y. Lu, S. L. Ryan, D. J. Elliott et al., "Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma," PLoS ONE, vol. 4, no. 7, Article ID e6159, 2009.
129. N. Karavitaki, S. Cudlip, C. B. T. Adams, and J. A. H. Wass, "Craniopharyngiomas," Endocrine Reviews, vol. 27, no. 4, pp. 371-397, 2006.
130. E. H. Nielsen, U. Feldt-Rasmussen, L. Poulsgaard et al., "Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults," Journal of Neuro-Oncology, vol. 104, no. 3, pp. 755-763, 2011.
131. G. R. Bunin, T. S. Surawicz, P. A. Witman, S. Preston-Martin, F. Davis, and J. M. Bruner, "The descriptive epidemiology of craniopharyngioma," Journal of Neurosurgery, vol. 89, no. 4, pp. 547-551, 1998.
132. C. L. Andoniadou, C. Gaston-Massuet, R. Reddy et al., "Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma," Acta Neuropathologica, vol. 124, no. 2, pp. 259-271, 2012.
133. X. Zhu, A. S. Gleiberman, and M. G. Rosenfeld, "Molecular physiology of pituitary development: signaling and transcriptional networks," Physiological Reviews, vol. 87, no. 3, pp. 933-963, 2007.
134. M. L. Campanini, L. M. Colli, B. M. C. Paixao et al., "CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas," Hormones and Cancer, vol. 1, no. 4, pp. 187-196, 2010.
135. Y. Fang, X. Gu, Z. Li, J. Xiang, and Z. Chen, "miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression," Oncology Reports, vol. 30, no. 1, pp. 399-406, 2013.
136. J. Geng, H. Luo, Y. Pu et al., "Methylation mediated silencing of miR-23b expression and its role in glioma stem cells," Neuroscience Letters, vol. 528, no. 2, pp. 185-189, 2012.
137. J. Finlay-Schultz, D. M. Cittelly, P. Hendricks et al., "Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a," Oncogene, 2014.
138. T. S. Armstrong, E. Vera-Bolanos, and M. R. Gilbert, "Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes Project," Cancer, vol. 117, no. 22, pp. 5133-5141, 2011.
139. H. Poppleton and R. J. Gilbertson, "Stem cells of ependymoma," British Journal of Cancer, vol. 96, no. 1, pp. 6-10, 2007.
140. M. D. Taylor, H. Poppleton, C. Fuller et al., "Radial glia cells are candidate stem cells of ependymoma," Cancer Cell, vol. 8, no. 4, pp. 323-335, 2005.
141. U. Tabori, V. Wong, J. Ma et al., "Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma," British Journal of Cancer, vol. 99, no. 7, pp. 1129-1135, 2008.
142. T. Tihan, T. Zhou, E. Holmes, P. C. Burger, S. Ozuysal, and E. J. Rushing, "The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors," Modern Pathology, vol. 21, no. 2, pp. 165-177, 2008.
143. F. F. Costa, J. M. Bischof, E. F. Vanin et al., "Identification of microRNAs as potential prognostic markers in ependymoma," PLoS ONE, vol. 6, no. 10, Article ID e25114, 2011.
144. Y. Li, Y. Yuan, K. Tao et al., "Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate," PLoS ONE, vol. 8, no. 4, Article ID e61858, 2013.
145. M. J. Bueno, I. P. de Castro, M. G. de Cedrón et al., "Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression," Cancer Cell, vol. 13, no. 6, pp. 496-506, 2008.
146. R. Yi, M. N. Poy, M. Stoffel, and E. Fuchs, "A skin microRNA promotes differentiation by repressing 'stemness'," Nature, vol. 452, no. 7184, pp. 225-229, 2008.
147. M. Sakurai, Y. Miki, M. Masuda et al., "LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer," Journal of Steroid Biochemistry and Molecular Biology, vol. 131, no. 3-5, pp. 101-106, 2012.
148. G. Tezcan, B. Tunca, A. Bekar et al., "microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells," Cellular and Molecular Neurobiology, vol. 34, no. 5, pp. 679-692, 2014.
149. E. J. Devor, J. N. de Mik, S. Ramachandran, M. J. Goodheart, and K. K. Leslie, "Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma," Experimental and Therapeutic Medicine, vol. 3, no. 4, pp. 677-682, 2012.
150. F. Haller, A. von Heydebreck, J. D. Zhang et al., "Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31," Journal of Pathology, vol. 220, no. 1, pp. 71-86, 2010.
151. P. Vasanthan, V. Govindasamy, N. Gnanasegaran, W. Kunasekaran, S. Musa, and N. H. Abu Kasim, "Differential expression of basal microRNAs' patterns in human dental pulp stem cells," Journal of Cellular and Molecular Medicine, vol. 19, no. 3, pp. 566-580, 2015.
152. R. Schneppenheim, M. C. Frühwald, S. Gesk et al., "Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome," The American Journal of Human Genetics, vol. 86, no. 2, pp. 279-284, 2010.
153. I. Versteege, N. Sévenet, J. Lange et al., "Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer," Nature, vol. 394, no. 6689, pp. 203-206, 1998.
154. K. Zhang, H. Gao, X. Wu et al., "Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA," Clinical Cancer Research, vol. 20, no. 5, pp. 1179-1189, 2014.
155. S. L. Yong and A. Dutta, "The tumor suppressor microRNA let-7 represses the HMGA2 oncogene," Genes and Development, vol. 21, no. 9, pp. 1025-1030, 2007.
156. C. Mayr, M. T. Hemann, and D. P. Bartel, "Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation," Science, vol. 315, no. 5818, pp. 1576-1579, 2007.
157. F. Yu, H. Yao, P. Zhu et al., "let-7 regulates self renewal and tumorigenicity of breast cancer cells," Cell, vol. 131, no. 6, pp. 1109-1123, 2007.
158. J. Takamizawa, H. Konishi, K. Yanagisawa et al., "Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival," Cancer Research, vol. 64, no. 11, pp. 3753-3756, 2004.
159. A. Malek, E. Bakhidze, A. Noske et al., "HMGA2 gene is a promising target for ovarian cancer silencing therapy," International Journal of Cancer, vol. 123, no. 2, pp. 348-356, 2008.
160. A. T. Yachnis, D. Neubauer, and D. Muir, "Characterization of a primary central nervous system atypical teratoid/rhabdoid tumor and derivative cell line: immunophenotype and neoplastic properties," Journal of Neuropathology and Experimental Neurology, vol. 57, no. 10, pp. 961-971, 1998.
161. J. A. Biegel, "Molecular genetics of atypical teratoid/rhabdoid tumor," Neurosurgical Focus, vol. 20, no. 4, p. E11, 2006.
162. D. M. Parham, D. A. Weeks, and J. B. Beckwith, "The clinicopathologic spectrum of putative extrarenal rhabdoid tumors: an analysis of 42 cases studied with immunohistochemistry or electron microscopy," American Journal of Surgical Pathology, vol. 18, no. 10, pp. 1010-1029, 1994.
163. S.-H. Chiou, C.-L. Kao, Y.-W. Chen et al., "Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor," PLoS ONE, vol. 3, no. 5, Article ID e2090, 2008.
164. C.-L. Kao, P.-I. Huang, P.-H. Tsai et al., "Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor," International Journal of Radiation Oncology Biology Physics, vol. 74, no. 1, pp. 219-228, 2009.
165. H.-I. Ma, C.-L. Kao, Y.-Y. Lee et al., "Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis," Child's Nervous System, vol. 26, no. 3, pp. 293-303, 2010.
166. S. L. Asa and S. Ezzat, "The pathogenesis of pituitary tumours," Nature Reviews Cancer, vol. 2, no. 11, pp. 836-849, 2002.
167. S. Ezzat and S. L. Asa, "Mechanisms of disease: the pathogenesis of pituitary tumors," Nature Clinical Practice Endocrinology and Metabolism, vol. 2, no. 4, pp. 220-230, 2006.
168. T. Palumbo, F. R. Faucz, M. Azevedo, P. Xekouki, D. Iliopoulos, and C. A. Stratakis, "Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway," Oncogene, vol. 32, no. 13, pp. 1651-1659, 2013.
169. H. Butz, I. Likó, S. Czirják et al., "Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas," Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 10, pp. E181-E191, 2010.
170. C. H. McGowan and P. Russell, "Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15," The EMBO Journal, vol. 12, no. 1, pp. 75-85, 1993.
171. B. N. Davis-Dusenbery and A. Hata, "Mechanisms of control of microRNA biogenesis," Journal of Biochemistry, vol. 148, no. 4, pp. 381-392, 2010.
172. A. Kotani, D. Ha, D. Schotte, M. L. DenBoer, S. A. Armstrong, and H. F. Lodish, "A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells," Cell Cycle, vol. 9, no. 6, pp. 1037-1042, 2010.
173. A. Maitra, I. I. Wistuba, C. Washington et al., "High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss," American Journal of Pathology, vol. 159, no. 1, pp. 119-130, 2001.
174. M. Li, W. Fu, L. Wo, X. Shu, F. Liu, and C. Li, "MiR-128 and its target genes in tumorigenesis and metastasis," Experimental Cell Research, vol. 319, no. 20, pp. 3059-3064, 2013.
175. S. Mi, J. Lu, M. Sun et al., "MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 50, pp. 19971-19976, 2007.
176. A. Bottoni, M. C. Zatelli, M. Ferrcin et al., "Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas," Journal of Cellular Physiology, vol. 210, no. 2, pp. 370-377, 2007.
177. A. H. Stegh, O. Schickling, A. Ehret et al., "DEDD, a novel death effect or domain-containing protein, targeted to the nucleolus," The EMBO Journal, vol. 17, no. 20, pp. 5974-5986, 1998.
178. Z. Mao, D. He, J. Zhou et al., "Differential expression of microRNAs in GH-secreting pituitary adenomas," Diagnostic Pathology, vol. 5, no. 1, article 79, 2010.
179. F. Salehi, K. Kovacs, B. W. Scheithauer, R. V. Lloyd, and M. Cusimano, "Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update," Endocrine-Related Cancer, vol. 15, no. 3, pp. 721-743, 2008.
180. F. Zhi, Q. Wang, D. Deng et al., "MiR-181b-5p downregulates NOVA1 to suppress proliferation, migration and invasion and promote apoptosis in astrocytoma," PLoS ONE, vol. 9, no. 10, Article ID e109124, 2014.
181. W. M. Pardridge, "shRNA and siRNA delivery to the brain," Advanced Drug Delivery Reviews, vol. 59, no. 2-3, pp. 141-152, 2007.
182. M. E. Hayes, D. C. Drummond, D. B. Kirpotin et al., "Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery," Gene Therapy, vol. 13, no. 7, pp. 646-651, 2006.
183. R. Saito, M. T. Krauze, C. O. Noble et al., "Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model," Neuro-Oncology, vol. 8, no. 3, pp. 205-214, 2006.
184. G. Chen, W. Zhu, D. Shi et al., "MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2," Oncology Reports, vol. 23, no. 4, pp. 997-1003, 2010.
185. L. Wang, Z. Shi, C. Jiang et al., "MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma," Oncotarget, vol. 5, no. 14, pp. 5416-5427, 2014.
186. J. Xu, X. Liao, and C. Wong, "Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05 MG," International Journal of Cancer, vol. 126, no. 4, pp. 1029-1035, 2010.
187. C.-Z. Zhang, J.-X. Zhang, A.-L. Zhang et al., "MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma," Molecular Cancer, vol. 9, article 229, 2010.
188. C. Shang, Y. Guo, Y. Hong, Y. Liu, and Y. Xue, "MiR-21 upregulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG," Molecular Biology Reports, vol. 42, no. 3, pp. 721-727, 2015.
189. B. X. Lei, Z. H. Liu, Z. J. Li, C. Li, and Y. F. Deng, "miR-21 induces cell proliferation and suppresses the chemosensitivity in glioblastoma cells via downregulation of FOXO1," International Journal of Clinical and Experimental Medicine, vol. 7, no. 8, pp. 2060-2066, 2014.
190. C. H. Yang, J. Yue, S. R. Pfeffer et al., "MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3)," The Journal of Biological Chemistry, vol. 289, no. 36, pp. 25079-25087, 2014.
191. C. H. Yang, S. R. Pfeffer, M. Sims et al., "The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis," The Journal of Biological Chemistry, vol. 290, no. 10, pp. 6037-6046, 2015.
192. I. S. Pateras, K. Apostolopoulou, K. Niforou, A. Kotsinas, and V. G. Gorgoulis, "p57KIP2: 'kip'ing the cell under control," Molecular Cancer Research, vol. 7, no. 12, pp. 1902-1919, 2009.
193. F. C. Amaral, N. Torres, F. Saggioro et al., "MicroRNAs differentially expressed in ACTH-secreting pituitary tumors," Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 1, pp. 320-323, 2009.
194. A. Catania, F. Maira, E. Skarmoutsou, F. D'Amico, R. Abounder, and M. C. Mazzarino, "Insight into the role of microRNAs in brain tumors (review)," International Journal of Oncology, vol. 40, no. 3, pp. 605-624, 2012.
195. E. Gentilin, F. Tagliati, C. Filieri et al., "MiR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase Cdelta," Endocrinology, vol. 154, no. 5, pp. 1690-1700, 2013.